Pregnancy-induced hypertension and preeclampsia: Levels of angiogenic factors in Malaysian women

Journal of Clinical Biochemistry and Nutrition

Volumn 47, Issue 3, 2010, Pages 191-197

  Yelumalai, Suseela ^a   Muniandy, Sekaran ^b   Omar, Siti Zawiah ^a   Qvist, Rajes ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Angiogenic factors; Endothelial dysfunction; Oxidative stress; Preeclampsia

Indexed keywords

ANGIOGENIC FACTOR; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS MORTALITY; GESTATIONAL AGE; HUMAN; MALAYSIA; MATERNAL HYPERTENSION; MATERNAL MORTALITY; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANT WOMAN; PUERPERIUM;

EID: 78049482011     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-27     Document Type: Article

References (40)

1. Mutter, W.P. and Karumanchi, S.A.: Molecular mechanisms of preeclampsia. Microvasc. Res., 75, 1-8, 2008.
2. Walker, J.J.: Pre-eclampsia. Lancet, 356, 1260-1265, 2000.
3. Redman, C.W. and Sargent, I.L.: Latest advances in understanding preeclampsia. Science, 308, 1592-1594, 2005.
4. Dekker, G.A. and Sibai, B.M.: Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol., 179, 1359-1375, 1998.
5. Roberts, J.M. and Gammill, H.S.: Preeclampsia: recent insights. Hypertension, 46, 1243-1249, 2005.
6. Noris, M., Perico, N., and Remuzzi, G.: Mechanisms of disease: Pre-eclampsia. Nat. Clin. Pract. Nephrol., 1, 98-114, 2005.
7. Maynard, S., Epstein, F.H., and Karumanchi, S.A.: Preeclampsia and angiogenic imbalance. Annu. Rev. Med., 59, 61-78, 2008.
8. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E., Epstein, F.H., Sukhatme, V.P., and Karumanchi, S.A.: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J .Clin. Invest., 111, 649-658, 2003.
9. Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O., and Taketani, Y.: Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J. Clin. Endocrinol. Metab., 88, 2348-2351, 2003.
10. Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J.F., Pignon, M.R., Noel, A., Schaaps, J.P., Cabrol, D., Frankenne, F., and Foidart, J.M.: Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J. Clin. Endocrinol. Metab., 88, 5555-5563, 2003.
11. Kendall, R.L., Wang, G., and Thomas, K.A.: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun., 226, 324-328, 1996.
12. Banks, R.E., Forbes, M.A., Searles, J., Pappin, D., Canas, B., Rahman, D., Kaufmann, S., Walters, C.E., Jackson, A., Eves, P., Linton, G., Keen, J., Walker, J.J., and Selby, P.J.: Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol. Hum. Reprod., 4, 377-386, 1998.
13. Shibuya, M.: Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int. J. Biochem. Cell Biol., 33, 409-420, 2001.
14. Autiero, M., Luttun, A., Tjwa, M., and Carmeliet, P.: Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J. Thromb. Haemost., 1, 1356-1370, 2003.
15. Levine, R.J., Maynard, S.E., Qian, C., Lim, K.H., England, L.J., Yu, K.F., Schisterman, E.F., Thadhani, R., Sachs, B.P., Epstein, F.H., Sibai, B.M., Sukhatme, V.P., and Karumanchi, S.A.: Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med., 350, 672-683, 2004.
16. Polliotti, B.M., Fry, A.G., Saller, D.N., Mooney, R.A., Cox, C., and Miller, R.K.: Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet. Gynecol., 101, 1266-1274, 2003.
17. Taylor, R.N., Grimwood, J., Taylor, R.S., McMaster, M.T., Fisher, S.J., and North, R.A.: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol., 188, 177-182, 2003.
18. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y.M., Bdolah, Y., Lim, K.H., Yuan, H.T., Libermann, T.A., Stillman, I.E., Roberts, D., D'Amore, P.A., Epstein, F.H., Sellke, F.W., Romero, R., Sukhatme, V.P., Letarte, M., and Karumanchi, S.A.: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med., 12, 642-649, 2006.
19. de Swiet, M.: Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am. J. Obstet. Gynecol., 182, 760-766, 2000.
20. Sibai, B.M., Ramadan, M.K., Usta, I., Salama, M., Mercer, B.M., and Friedman, S.A.: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol., 169, 1000-1006, 1993.
21. Shibata, E., Rajakumar, A., Powers, R.W., Larkin, R.W., Gilmour, C., Bodnar, L.M., Crombleholme, W.R., Ness, R.B., Roberts, J.M., and Hubel, C.A.: Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J. Clin. Endocrinol. Metab., 90, 4895-4903, 2005.
22. Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., Sibai, B.M., Epstein, F.H., Romero, R., Thadhani, R., Karumanchi, S.A., and CPEP Study Group: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med., 355, 992-1005, 2006.
23. Zhou, Y., McMaster, M., Woo, K., Janatpour, M., Perry, J., Karpanen, T., Alitalo, K., Damsky, C., and Fisher, S.J.: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol., 160, 1405-1423, 2002.
24. Hirokoshi, K., Maeshima, Y., Kobayashi, K., Matsuura, E., Sugiyama, H., Yamasaki, Y., Masuyama, H., Hiramatsu, Y., and Makino, H.: Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia. Nephron. Clin. Pract., 106, c43-50, 2007.
25. Baker, P.N., Krasnow, J., Roberts, J.M., and Yeo, K.T.: Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet. Gynecol., 86, 815-821, 1995.
26. Bosio, P.M., Wheeler, T., Anthony, F., Conroy, R., O'herlihy, C., and McKenna, P.: Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am. J. Obstet. Gynecol., 184, 146-152, 2001.
27. Hunter, A., Aitkenhead, M., Caldwell, C., McCracken, G., Wilson, D., and McClure, N.: Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension, 36, 965-969, 2000.
28. Sharkey, A.M., Cooper, J.C., Balmforth, J.R., McLaren, J., Clark, D.E., Charnock-Jones, D.S., Morris, N.H., and Smith, S.K.: Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur. J. Clin. Invest., 26, 1182-1185, 1996.
29. Park, C.W., Park, J.S., Shim, S.S., Jun, J.K., Yoon, B.H., and Romero, R.: An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. Am. J. Obstet. Gynecol., 193, 984-989, 2005.
30. Zhou, Y., Damsky, C.H., and Fisher, S.J.: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J. Clin. Invest., 99, 2152-2164, 1997.
31. Wathen, K.A., Tuutti, E., Stenman, U.H., Alfthan, H., Halmesmaki, E., Finne, P., Ylikorkala, O., and Vuorela, P.: Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J. Clin. Endocrinol. Metab., 91, 180-184, 2006.
32. Powers, R.W., Roberts, J.M., Cooper, K.M., Gallaher, M.J., Frank, M.P., Harger, G.F., and Ness, R.B.: Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am. J. Obstet. Gynecol., 193, 185-191, 2005.
33. Thadhani, R., Mutter, W.P., Wolf, M., Levine, R.J., Taylor, R.N., Sukhatme, V.P., Ecker, J., and Karumanchi, S.A.: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J. Clin. Endocrinol. Metab., 89, 770-775, 2004.
34. Levine, R.J., Thadhani, R., Qian, C., Lam, C., Lim, K.H., Yu, K.F., Blink, A.L., Scahs, B.P., Epstein, F.H., Sibai, B.M., Sukhatme, V.P., and Karumanchi, S.A.: Urinary placental growth factor and risk of preeclampsia. JAMA, 293, 77-85, 2005.
35. Heeschen, C., Jang, J.J., Weis, M., Pathak, A., Kaji, S., Hu, R.S., Tsao, P.S., Johnson, F.L., and Cooke, J.P.: Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med., 7, 833-839, 2001.
36. Newman, M.G., Lindsay, M.K., and Graves, W.: Cigarette smoking and pre-eclampsia: their association and effects on clinical outcomes. J. Matern. Fetal. Med., 10, 166-170, 2001.
37. Belgore, F.M., Lip, G.Y., and Blann, A.D.: Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br. J. Biomed. Sci., 57, 207-213, 2000.
38. Chappell, L.C., Seed, P.T., Kelly, F.J., Briley, A., Hunt, B.J., Charnock-Jones, D.S., Mallet, A., and Poston, L.: Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am. J. Obstet. Gynecol., 187, 777-784, 2002.
39. Chappell, L.C., Seed, P.T., Briley, A.L., Kelly, F.J., Lee, R., Hunt, B.J., Parmer, K., Bewley, S.J., Shennan, A.H., Steer, P.J., and Poston, L.: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet, 354, 810-816, 1999.
40. Suhail, M., Faizul Suhail, M., and Khan, H.: Role of vitamins C and e in regulating antioxidant and pro-oxidant markers in preeclampsia. J. Clin. Biochem. Nutr., 43, 210-220, 2008.